Drug Database
Back to search

Netherlands· NL-c162a3e89940

Axhidrox 8 mg/g, crème

A glycopyrronium product containing glycopyrroniumbromide, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC D11AA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAxhidrox 8 mg/g, crèmeATCD11AA01REGISTER NO.NL-c162a3e89940PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about glycopyrroniumbromideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Glycopyrronium is registered in 14 of 19 countries.

Countries holding a registration under ATC D11AA01 (glycopyrronium), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search glycopyrronium products by name

Glycopyrronium · ATC D11AA01

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
GLYCOPYRRONIUMBROMIDE
Manufacturer
Euro Registratie Collectief B.V.
Country
Netherlands (NL)
ATC code
D11AA01
ATC class
Glycopyrronium
Defined daily dose
8.8 mg, T
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    133873//128057

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

108 interactions on record for glycopyrronium.

Graded by severity as the source publishes them — 107 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check glycopyrronium against other medicinesHow interaction checks work

Glycopyrronium · interactions on record

108 records

  • 107 moderate
  • 1 minor

Most severe, free to view

  • DicycloverineA03AA07moderate
  • PropanthelineA03AB05moderate
  • MepenzolateA03AB12moderate
  • TrospiumA03AB20moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glycopyrronium in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glycopyrronium products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Austria · Rybrila
  • Germany · Rybrila
  • Spain · Axhidrox
  • Sweden · Glycopyrronium Cantabria

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/62d111ad-f087-4c48-91b4-84cd1424f387
GET /v1/drugs/62d111ad-f087-4c48-91b4-84cd1424f387?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Crème",
  "route": "Cutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h128057_smpc.pdf",
  "strength": null,
  "atc_label": "Glycopyrronium",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg133873",
  "excipients": [
    "BENZYLALCOHOL (E 1519)",
    "CETOSTEARYLALCOHOL",
    "CITROENZUUR 0-WATER (E 330)",
    "GLYCEROLMONOSTEARAAT 40-55 (E 471)",
    "MACROGOL 20 GLYCEROL MONOSTEARAAT",
    "OCTYLDODECANOL",
    "PROPYLEENGLYCOL (E 1520)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "GLYCOPYRRONIUMBROMIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h133873.pdf",
  "authorised_at": "2025/02/26",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "133873//128057",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about glycopyrronium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console